T2	location 332 340	Austrian
T3	eligibility 85 125	women with favorable early breast cancer
T4	total-participants 408 411	869
T6	intervention-participants 464 467	414
T7	control 472 475	not
T8	control-participants 481 484	417
T9	outcome-Measure 943 970	local relapse-free survival
T11	age 1138 1146	66 years
T12	outcome 1171 1185	local relapses
T13	iv-bin-abs 1192 1193	2
T14	outcome 1230 1238	5-y rate
T15	iv-bin-percent 1239 1243	0.4%
T16	control-participants 1249 1251	19
T17	cv-bin-percent 1282 1286	5.1%
T20	outcome 1335 1351	Overall relapses
T21	iv-bin-abs 1382 1383	7
T22	outcome 1418 1426	5-y rate
T23	iv-bin-percent 1427 1431	2.1%
T24	cv-bin-abs 1437 1439	23
T25	cv-bin-percent 1477 1481	6.1%
T1	intervention 0 81	Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation
T5	outcome 1556 1574	distant metastases
T18	outcome 1579 1595	overall survival
T10	outcome-Measure 995 1022	contralateral breast cancer
T19	outcome-Measure 1024 1042	distant metastases
T26	outcome-Measure 1048 1081	disease-free and overall survival
